Mechanistically, TGF-β promotes stromal remodeling and epithelial-to-mesenchymal transition, which generate an immune-excluded tumor microenvironment by preventing CD8 + T-cell infiltration [10]. The gene discussed is TGFB1; the disease is neoplasm.